Displaying 11–20 of 283 research results
Oct 3, 2022
Small data sets present challenges for developing rare disease AI tools
Sep 8, 2022
The company plans to seek FDA approval for the emerging therapy in first quarter of 2023
Aug 25, 2022
The company’s drug is designed to reduce accumulation of toxins that cause vision loss.
Aug 11, 2022
The company is halting its clinical programs for LCA10 and USH2A as it seeks a new partner
Aug 10, 2022
Funding for the new grants was made possible by Foundation’s strong donor base and philanthropic partners
Jul 25, 2022
The emerging therapy is designed to restore vision for people with advanced retinal degenerative diseases
Jul 22, 2022
There are currently no FDA-approved therapies for geographic atrophy (GA), the advanced form of dry AMD.
Jul 14, 2022
The emerging treatment is gene-agnostic.
Jun 27, 2022
The approach bestows light sensitivity to retinal ganglion cells for people who have lost their photoreceptors
Jun 20, 2022
The newly approved drug reduces the pathologic hunger associated with BBS